Control Bionics offers a suite of dedicated speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice. Our product range is more intuitive and flexible than ever, giving users the power to make life-changing connections. Control Bionics makes NeuroNode, a sixth generation computer-human-interface (CHI) system that is designed to enable people with severe disabilities to communicate with their loved ones, carers, friends and the world at large with text, text-to-speech (TTS), instant messaging (IM), emails and the internet; and to control their own entertainment media (music, videos and online services) as well as expanding their own creativity with word processing, music and video editing, and design programs.
View Top Employees from Control Bionics (ASX:CBL)Website | http://www.controlbionics.com |
Revenue | $11 million |
Employees | 41 (41 on RocketReach) |
Founded | 2006 |
Address | 697 Burke Rd, Lvl 5, Suite 5.01, Camberwell, Victoria 3124, AU |
Phone | (855) 831-7521 |
Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
Industry | Retail, Medical Devices |
Competitors | Alon MedTech Ventures, ControlRad, Imricor, Microbot Medical, Vascular Dynamics |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular Control Bionics (ASX:CBL) employee's phone or email?
The Control Bionics (ASX:CBL) annual revenue was $11 million in 2024.
Jeremy Steele is the CEO of Control Bionics (ASX:CBL).
41 people are employed at Control Bionics (ASX:CBL).
Control Bionics (ASX:CBL) is based in Camberwell, Victoria.
The NAICS codes for Control Bionics (ASX:CBL) are [33, 334].
The SIC codes for Control Bionics (ASX:CBL) are [384, 38].